Published in Am Heart J on July 01, 2009
Epidemiology of arrhythmias and conduction disorders in older adults. Clin Geriatr Med (2012) 0.96
Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat. Cardiovasc Diabetol (2010) 0.85
Investigation on cardiovascular risk prediction using physiological parameters. Comput Math Methods Med (2013) 0.79
Health promotion activities of sports clubs and coaches, and health and health behaviours in youth participating in sports clubs: the Health Promoting Sports Club study. BMJ Open Sport Exerc Med (2015) 0.75
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation (2007) 20.44
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med (1999) 7.59
The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69
Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87
Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA (2000) 3.24
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation (1987) 3.16
Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol (1999) 2.36
Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med (2008) 2.35
Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc (1997) 2.14
Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation (2001) 2.10
QRS duration and mortality in patients with congestive heart failure. Am Heart J (2002) 2.10
Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol (1985) 2.03
Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation (1994) 1.86
An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram. Ann Intern Med (2007) 1.80
Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart (1998) 1.68
Repolarization abnormality for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. J Cardiovasc Electrophysiol (2005) 1.47
Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA (2007) 1.47
Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up. Am J Cardiol (2003) 1.42
Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease: the Framingham Study. Am Heart J (1987) 1.39
Independent contribution of electrocardiographic abnormalities to risk of death from coronary heart disease, cardiovascular diseases and all causes. Findings of three Chicago epidemiologic studies. Circulation (1982) 1.26
Relative survival analysis in R. Comput Methods Programs Biomed (2006) 1.25
QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension (2004) 1.25
Long-term prognostic significance of isolated minor electrocardiographic T-wave abnormalities in middle-aged men free of clinical cardiovascular disease (The Multiple Risk Factor Intervention Trial [MRFIT]). Am J Cardiol (2002) 1.15
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension (2004) 1.12
Silent ST-T changes in an epidemiologic cohort study--a marker of hypertension or coronary heart disease, or both: the Reykjavik study. J Am Coll Cardiol (1996) 1.08
Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes (2004) 1.07
The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol (1988) 1.07
Electrocardiograms and 13 year cardiovascular mortality in Busselton study. Br Heart J (1982) 1.05
External prognostic validations and comparisons of age- and gender-adjusted exercise capacity predictions. J Am Coll Cardiol (2007) 0.95
Quantitative measures of electrocardiographic left ventricular mass, conduction, and repolarization, and long-term survival after coronary artery bypass grafting. Circulation (2007) 0.82
Computerized ST depression analysis improves prediction of all-cause and cardiovascular mortality: the strong heart study. Ann Noninvasive Electrocardiol (2001) 0.82
Usefulness of exercise-induced ST-segment depression in the inferior leads during exercise testing as a marker for coronary artery disease. Am J Cardiol (1992) 0.79
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med (2013) 5.10
The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03
Inflammation as a risk factor for atrial fibrillation. Circulation (2003) 4.95
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med (2006) 4.59
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol (2010) 4.52
A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46
Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A (2007) 3.92
Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87
Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50
Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med (2012) 3.47
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 3.38
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA (2004) 3.34
Use of annulus washer after debridement: a new mitral valve replacement technique for patients with severe mitral annular calcification. J Thorac Cardiovasc Surg (2013) 3.31
The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med (2002) 3.01
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology (2002) 2.87
Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA (2006) 2.82
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol (2003) 2.76
Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA (2011) 2.73
Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. J Thorac Cardiovasc Surg (2010) 2.69
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A (2008) 2.64
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation (2004) 2.54
Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg (2006) 2.42
Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg (2004) 2.37
A novel approach to cancer staging: application to esophageal cancer. Biostatistics (2009) 2.31
Surgical treatment of postinfarction left ventricular pseudoaneurysm. Ann Thorac Surg (2007) 2.26
Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation (2005) 2.26
Are all readmissions bad readmissions? N Engl J Med (2010) 2.22
Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol (2007) 2.20
Refining esophageal cancer staging. J Thorac Cardiovasc Surg (2003) 2.18
Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg (2010) 2.16
A randomized trial of massage therapy after heart surgery. Heart Lung (2009) 2.13
Editorial: An 'actual' problem: Another issue of apples and oranges. J Heart Valve Dis (2005) 2.11
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09
Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08
Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation (2013) 2.07
Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg (2004) 2.03
Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. J Thorac Cardiovasc Surg (2008) 1.99
Random forests for genomic data analysis. Genomics (2012) 1.98
Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg (2007) 1.91
Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation (2005) 1.88
Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg (2006) 1.88
Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg (2006) 1.80
Truncus arteriosus associated with interrupted aortic arch in 50 neonates: a Congenital Heart Surgeons Society study. Ann Thorac Surg (2006) 1.78
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72
Toward predictable repair of regurgitant aortic valves: a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol (2008) 1.71
What is the preferred therapy for patients with aortic coarctation--the standard gamble and decision analysis versus real results? Cardiol Young (2007) 1.71
Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg (2006) 1.71
Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg (2006) 1.71
Time for a creative transformation of epidemiology in the United States. JAMA (2012) 1.70
A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg (2008) 1.69
Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg (2003) 1.69
A novel running annuloplasty suture technique for robotically assisted mitral valve repair. J Thorac Cardiovasc Surg (2010) 1.68
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66
Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg (2002) 1.66
Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg (2003) 1.65
Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg (2008) 1.65
The rudimentary phase of personalised medicine: coronary risk scores. Lancet (2003) 1.65
Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol (2002) 1.64
Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2009) 1.64
Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg (2008) 1.64
Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg (2009) 1.63
Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation (2009) 1.63